Risk factors associated with symptoms of gastroesophageal reflux

American Journal of Medicine

Volumn 106, Issue 6, 1999, Pages 642-649

  Locke III, G Richard ^a   Talley, Nicholas J ^a   Fett, Sara L ^a   Zinsmeister, Alan R ^a   Melton III, L Joseph ^a  

^a MAYO CLINIC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; FAMILY HISTORY; FEMALE; GASTROESOPHAGEAL REFLUX; GENETICS; HEARTBURN; HUMAN; LIFESTYLE; MAJOR CLINICAL STUDY; MALE; OBESITY; POPULATION RESEARCH; PRIORITY JOURNAL; RISK FACTOR; STOMACH ACID; SYMPTOMATOLOGY; WEIGHT REDUCTION;

ADULT; AGED; CROSS-SECTIONAL STUDIES; FEMALE; GASTROESOPHAGEAL REFLUX; HUMANS; LOGISTIC MODELS; MALE; MIDDLE AGED; MINNESOTA; ODDS RATIO; QUESTIONNAIRES; RISK; RISK FACTORS;

EID: 0033029057     PISSN: 00029343     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0002-9343(99)00121-7     Document Type: Article

References (54)

1. Kahrilas P.J. Gastroesophageal reflux disease. JAMA. 276:1996;983-988.
2. Johnsson F., Joelsson B., Isberg P.-E. Ambulatory 24 hour intraesophageal pH-monitoring in the diagnosis of gastroesophageal reflux disease. Gut. 28:1987;1145-1150.
3. Schindlbeck N.E., Ippisch H., Klauser A.G., Muller-Lissner S.A. Which pH threshold is best in esophageal pH monitoring? Am J Gastroenterol. 86:1991;1138-1141.
4. Richter J.E., Bradley L.A., DeMeester T.R., Wu W.C. Normal 24-Hr ambulatory esophageal pH values. Dig Dis Sci. 37:1992;849-856.
5. Jamieson J.R., Stein H.J., DeMeester T.R., et al. Ambulatory 24-h esophageal pH monitoring normal values, optimal thresholds, specificity, sensitivity, and reproducibility . Am J Gastroenterol. 87:1992;1102-1111.
6. Fuchs K.H., DeMeester T.R., Albertucci M. Specificity and sensitivity of objective diagnosis of gastroesophageal reflux disease. Surgery. 102:1987;575-580.
7. Johnsson F., Joelsson B., Gudmundsson K., Greiff L. Symptoms and endoscopic findings in the diagnosis of gastroesophageal reflux disease. Scand J Gastroenterol. 22:1987;714-718.
8. Cameron A.J., Lomboy C.T. Barrett's esophagus age, prevalence, and extent of columnar epithelium . Gastroenterology. 103:1992;1241-1245.
9. Mann N.S., Tsai M.F., Nair P.K. Barrett's esophagus in patients with symptomatic reflux esophagitis. Am J Gastroenterol. 84:1989;1494-1496.
10. Winters C. Jr, Spurling T.J., Chobanian S.J., et al. Barrett's esophagus a prevalent, occult complication of gastroesophageal reflux disease . Gastroenterology. 92:1987;118-124.
11. Spechler S.J. Epidemiology and natural history of gastro-oesophageal reflux disease. Digestion. 51:(suppl 1):1992;24-29.
12. Blot W.J., Devesa S.S., Kneller R.W., Fraumeni J.F. Jr. Rising incidence of adenocarcinoma of the esophagus and gastric cardia. JAMA. 265:1991;1287-1289.
13. Pera M., Cameron A.J., Trastek V.F., et al. Increasing incidence of adenocarcinoma of the esophagus and esophagogastric junction. Gastroenterology. 104:1993;510-513.
14. Cameron A.J., Ott B.J., Payne W.S. The incidence of adenocarcinoma in columnar-lined (Barrett's) esophagus. NEJM. 313:1985;857-859.
15. Spechler S.J., Robbins A.H., Rubins H.B., et al. Adenocarcinoma and Barrett's esophagus an overrated risk? Gastroenterology. 87:1984;927-933.
16. Klauser A.F., Schindlbeck N.E., Muller-Lissner S.A. Symptoms in gastro-oesophageal reflux disease. Lancet. 335:1990;205-208.
17. Wienbeck M., Barnert J. Epidemiology of reflux disease and reflux esophagitis. Scand J Gastroenterol. 24:(suppl 156):1989;7-13.
18. Nebel O.T., Fornes M.F., Castell D.O. Symptomatic gastroesophageal reflux incidence and precipitating factors . Dig Dis. 21:1976;953-956.
19. Thompson W.G., Heaton K.W. Heartburn and globus in apparently healthy people. J Can Med Assoc. 126:1982;46-48.
20. A Gallup Survey on Heartburn Across America. Princeton, NJ: The Gallup Organization, Inc, 1988.
21. Ruth M., Mansson I., Sandberg N. The prevalence of symptoms suggestive of esophageal disorders. Scand J Gastroenterol. 26:1991;73-81.
22. Andersen L.I., Jensen G. Prevalence of benign oesophageal disease in the Danish population with special reference to pulmonary disease. J Intern Med. 225:1989;393-402.
23. Kay L., Jorgensen T. Epidemiology of upper dyspepsia in a random population. Scand J Gastroenterol. 29:1994;1-6.
24. Agreus L., Svardsudd K., Nyren O., Tibblin G. The epidemiology of abdominal symptoms prevalence and demographic characteristics in a Swedish adult population . Scand J Gastroenterol. 29:1994;102-109.
25. Isolauri J., Laippala P. Prevalence of symptoms suggestive of gastroesophageal reflux disease in an adult population. Ann Med. 27:1995;67-70.
26. Locke G.R., Talley N.J., Fett S.L., et al. Prevalence and clinical spectrum of gastroesophageal reflux a population-based study in Olmsted County, Minnesota . Gastroenterology. 112:1997;1448-1456.
27. Brown DM, Everhart JE. Cost of digestive disease in the United States. In: Everhart JE, ed. Digestive Disease in the United States: Epidemiology and Impact. US Department of Health and Human Services, Public Health Service, National Institutes of Health, National Institute of Diabetes, Digestive and Kidney Disease. Washington, DC: US Government Printing Office, 1994. NIH Publication 94-1447:55.
28. Kitchin L.I., Castell D.O. Rationale and efficacy of conservative therapy for gastroesophageal reflux disease. Arch Intern Med. 151:1991;448-454.
29. Ryan P., Hetzel D.J., Shearman D.J., McMichael A.J. Risk factors for ulcerative reflux oesophagitis a case-control study . J Gastroenterol Hepatol. 10:1995;306-312.
30. Andersen L.I., Jensen G. Risk factors for benign oesophageal disease in a random population sample. J Intern Med. 230:1991;5-10.
31. Prior A., Whorwell P.J. Familial Barrett's esophagus? Hepato-Gastroenterol. 33:1986;86-87.
32. Crabb D.W., Berk M.A., Hall T.R., et al. Familial gastroesophageal reflux and development of Barrett's esophagus. Ann Int Med. 103:1985;52-54.
33. Jochem V.J., Fuerst P.A., Fromkes J.J. Familial Barrett's esophagus associated with adenocarcinoma. Gastroenterology. 102:1992;1400-1402.
34. Fahmy M., King J.F. Barrett's esophagus an acquired condition with genetic predisposition . Am J Gastroenterol. 88:1993;1261-1265.
35. Eng C., Spechler S.J., Ruben R., Li F.P. Familial Barrett esophagus and adenocarcinoma of the gastroesophageal junction. Cancer Epidemiol Biomarkers Prev. 2:1993;397-399.
36. Gelfand M.D. Barrett esophagus in sexagenarian identical twins. J Clin Gastroenterol. 5:1983;251-253.
37. Schulz-Delrieu K., Anuras S. Chronic esophagitis in two sisters. Dig Dis Sci. 28:1983;1101-1105.
38. Graham D.Y., Smith J.L., Patterson D.J. Why do apparently healthy people use antacid tablets? Am J Gastroenterol. 78:1983;257-260.
39. Klinkenberg-Knol E., Castell D.O. Clinical spectrum and diagnosis of gastroesophageal reflux disease. Castell D.O. The Esophagus. 1993;441-448 Little, Brown, Boston.
40. Melton L.J. History of the Rochester Epidemiology Project. Mayo Clin Proc. 71:1996;266-274.
41. Talley N.J., Zinsmeister A.R., Van Dyke C., Melton L.J. III. Epidemiology of colonic symptoms and the irritable bowel syndrome. Gastroenterology. 101:1991;927-934.
42. Talley N.J., Zinsmeister A.R., Schleck C.D., Melton L.J. III. Dyspepsia and dyspepsia subgroups population-based study . Gastroenterology. 102:1992;1259-1268.
43. Talley N.J., Weaver A.L., Zinsmeister A.R., Melton L.J. III. Onset and disappearance of gastrointestinal symptoms and functional gastrointestinal disorders. Am J Epidemiol. 136:1992;165-177.
44. Talley N.J., Weaver A.L., Zinsmeister A.R., Melton L.J. III. Functional constipation and outlet delay a population-based study . Gastroenterology. 105:1993;781-790.
45. Talley N.J., Fett S.L., Zinsmeister, Melton L.J. III. Gastrointestinal tract symptoms and self-reported abuse a population-based study . Gastroenterology. 107:1994;1040-1049.
46. Locke G.R., Talley N.J., Weaver A.L., Zinsmeister A.R. A new questionnaire for gastroesophageal reflux disease. Mayo Clin Proc. 69:1994;539-547.
47. Attanasio V., Andrasik F., Blanchard E.B., Arena J.G. Psychometric properties of the SUNYA revision of the psychosomatic symptom checklist. J Behav Med. 7:1984;247-258.
48. SAS Institute, Inc. SAS/STAT Users Guide, Version 6, 4th ed, vol 2. Cary, NC, 1989: 1071.
49. Romero Y., Cameron A.J., Locke G.R., et al. Familial aggregation of gastroesophageal reflux in patients with Barrett's esophagus and esophageal adenocarcinoma. Gastroenterology. 113:1997;1449-1456.
50. Dennish G.W., Castell D.O. Inhibitory effect of smoking on the lower esophageal sphincter. NEJM. 284:1971;1136-1137.
51. Stanciu C., Bennett J.R. Smoking and gastroesophageal reflux. BMJ. 3:1972;793-795.
52. Hogan W.J., Viegas de Andrade S.R., Winship D.H. Ethanol-induced acute esophageal motor dysfunction. J Appl Physiol. 32:1972;755-760.
53. Brazer S.R., Onken J.E., Dalton C.B., et al. Effect of different coffees on esophageal acid contact time and symptoms in coffee-sensitive subjects. Physiol Behav. 57:1995;563-567.
54. Richter J.E., Castell D.O. Gastroesophageal reflux pathogenesis, diagnosis, and therapy . Ann Intern Med. 97:1982;93-103.